DARE: Daré Bioscience, Inc. Company Value to Net Income

Dare Bioscience - graphic logo of issuer DARE

The price action of Dare Bioscience, Inc. (DARE) demonstrates the -1.30 indicator. Dare Bioscience, Inc. (DARE) develops cutting-edge gynecological treatments, aiming to secure a dominant market position following patent registration due to low demand elasticity. The business relies on the development of exclusive long-term treatment products, which minimizes competitive risks. The brand's impeccable scientific reputation ensures steady support from specialized investment funds.

Price to Earnings Ratio: Dare Bioscience Inc. (DARE) for 07/04/2022 - 11/11/2026

Comprehensive metric breakdowns and analytics for Dare Bioscience Inc. (DARE)

- price and consensus price forecast:
Stock Price darebioscience.com|DARE - Consensus Target
- market capitalization information:
Market Value Dare Bioscience|DARE - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Accounting Value per Share Daré Bioscience|DARE - Company Book Value|Market-to-Book Ratio darebioscience.com|DARE - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Dare Bioscience, Inc.|DARE - Long-Term Debt to Capital|Current Liabilities to Capital Daré Bioscience, Inc.|DARE - Company Debts|Debt to Book Value Ratio Dare Bioscience|DARE - Company Long-Term Debts|Company Short-Term Indebtedness Daré Bioscience|Quick Ratio darebioscience.com
- company profitability and valuation multiples indicators:
DARE - Company Net Income|Expected Net Income Dare Bioscience, Inc.|DARE - P/E Multiple|Projected Price to Earnings Ratio Dare Bioscience|DARE - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Dare Bioscience|DARE - Operating profit EBITDA|Earnings per share for the last twelve months Daré Bioscience|DARE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months darebioscience.com|DARE - Earnings per share growth in current year|Expected net earnings per share growth next year Dare Bioscience, Inc.
Comprehensive company analysis:darebioscience.com DARE
Signature product of Daré Bioscience

Professional managers utilize fundamental filters to determine the overpayment per unit of net profit, using this ratio to measure the investment payback period. The current P/E dynamics of Dare Bioscience, Inc. (DARE) reflect market expectations for the company's long-term patents on gel therapies, transforming price volatility into an objective indicator of the value of future royalties from women's health products.

Key competitors

P/E Multiple organon.com|Price to Earnings Ratio TXMD (TherapeuticsMD, Inc.)|PTN (Palatin Technologies Inc) - Company Value to Net Income